Clemizole and modulators of serotonin signalling suppress seizures in Dravet syndrome.
about
Screening of conventional anticonvulsants in a genetic mouse model of epilepsy.The Power of Zebrafish in Personalised Medicine.Behavioral Comorbidities and Drug Treatments in a Zebrafish scn1lab Model of Dravet Syndrome.Serotonergic modulation as a pharmacological modality in the treatment of Dravet syndromePyridoxine-Dependent Epilepsy in Zebrafish Caused by Aldh7a1 Deficiency.A novel metabolism-based phenotypic drug discovery platform in zebrafish uncovers HDACs 1 and 3 as a potential combined anti-seizure drug target.Brain activity patterns in high-throughput electrophysiology screen predict both drug efficacies and side effects.Genomics-Guided Precise Anti-Epileptic Drug Development.An automated system for rapid cellular extraction from live zebrafish embryos and larvae: Development and application to genotyping.Expanding the Zebrafish Toolkit for Epilepsy Research.Fenfluramine diminishes NMDA receptor-mediated seizures via its mixed activity at serotonin 5HT2A and type 1 sigma receptors.Zebrafish Models of Rare Hereditary Pediatric Diseases.Preclinical Animal Models for Dravet Syndrome: Seizure Phenotypes, Comorbidities and Drug Screening.Zebrafish Models of Neurodevelopmental Disorders: Past, Present, and FutureCalcium imaging and dynamic causal modelling reveal brain-wide changes in effective connectivity and synaptic dynamics during epileptic seizuresLorcaserin therapy for severe epilepsy of childhood onset: A case series
P2860
Q33646252-B298B85F-A234-43B1-B9D3-562E283A2C49Q38608686-DAFDB4FE-FE71-4247-9790-0030538B2F56Q41379608-0411B386-7A2F-47CD-8D7D-D010E329A00BQ42243944-600BFE36-90FB-422C-82F8-5B4015AF7B4FQ47164777-467EB5B9-3AA6-448C-B5CB-40D4D0380429Q47709789-82B411F9-BB27-4359-8200-30FD0E9A9FC1Q47863623-B43FA969-4CA8-43D0-B8FD-B153B1B18EFDQ48634670-B0B4D119-4CDA-41E9-9B4E-A84EB31A8B1EQ52430829-54C13123-0723-4A08-8DB3-764B17882C6AQ55031584-805B1A9C-8C92-4EFF-A9E4-D4364D298F33Q55340475-6096FF2F-7D2A-4562-88D3-348B66B08005Q55429803-F7E290BD-8B4B-450E-AD02-89D81049F679Q55471525-E2C177C1-F93E-4382-9F7A-5D561CD15219Q57166914-FD48307B-B79B-4CE7-84B5-371E57FA9493Q57720829-824B7EA9-33D1-4176-89C7-FA143CAE7784Q58694358-E161FCD1-4F6C-4BCD-83AE-3591E11150ED
P2860
Clemizole and modulators of serotonin signalling suppress seizures in Dravet syndrome.
description
2017 nî lūn-bûn
@nan
2017年の論文
@ja
2017年論文
@yue
2017年論文
@zh-hant
2017年論文
@zh-hk
2017年論文
@zh-mo
2017年論文
@zh-tw
2017年论文
@wuu
2017年论文
@zh
2017年论文
@zh-cn
name
Clemizole and modulators of serotonin signalling suppress seizures in Dravet syndrome.
@ast
Clemizole and modulators of serotonin signalling suppress seizures in Dravet syndrome.
@en
type
label
Clemizole and modulators of serotonin signalling suppress seizures in Dravet syndrome.
@ast
Clemizole and modulators of serotonin signalling suppress seizures in Dravet syndrome.
@en
prefLabel
Clemizole and modulators of serotonin signalling suppress seizures in Dravet syndrome.
@ast
Clemizole and modulators of serotonin signalling suppress seizures in Dravet syndrome.
@en
P2093
P2860
P50
P356
P1433
P1476
Clemizole and modulators of serotonin signalling suppress seizures in Dravet syndrome.
@en
P2093
Kelly Knupp
Luke P Lee
SoonGweon Hong
P2860
P304
P356
10.1093/BRAIN/AWW342
P407
P577
2017-01-10T00:00:00Z